Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

KVUE

Kenvue Inc

Oct 28 • 04:00PM ET

14.51

-0.57 -3.78 %

Consumer Defensive • Household & Personal Products • USA • NYSE

Peers: PG CL CHD JNJ EL KMB UL REYN ULTA

| Held by: VTI VOO VO IVV SPY XLP VTV MOAT SDY VOE

Scroll to Statements

Index	S&P 500	P/E	19.71	EPS (ttm)	0.74	Insider Own	0.05%	Shs Outstand	1.92B	Perf Week	-2.81%
Market Cap	27.85B	Forward P/E	13.05	EPS next Y	1.11	Insider Trans	0.00%	Shs Float	1.92B	Perf Month	-11.20%
Enterprise Value	35.52B	PEG	13.78	EPS next Q	0.26	Inst Own	100.42%	Short Float	1.51%	Perf Quarter	-33.07%
Income	1.42B	P/S	1.84	EPS this Y	-9.78%	Inst Trans	0.27%	Short Ratio	0.99	Perf Half Y	-37.94%
Sales	15.14B	P/B	2.59	EPS next Y	8.09%	ROA	5.29%	Short Interest	29.03M	Perf YTD	-32.04%
Book/sh	5.59	P/C	26.02	EPS next 5Y	1.43%	ROE	13.56%	52W High	25.17 -42.35%	Perf Year	-36.83%
Cash/sh	0.56	P/FCF	17.11	EPS past 3/5Y	-20.60% -6.66%	ROIC	7.93%	52W Low	14.05 3.27%	Perf 3Y	-
Dividend Est.	0.83 (5.70%)	EV/EBITDA	10.68	Sales past 3/5Y	0.91% 1.54%	Gross Margin	58.12%	Volatility	2.86% 3.88%	Perf 5Y	-
Dividend TTM	0.82 (5.67%)	EV/Sales	2.35	EPS Y/Y TTM	26.65%	Oper. Margin	17.95%	ATR (14)	0.64	Perf 10Y	-
Dividend Ex-Date	Aug 13, 2025	Quick Ratio	0.68	Sales Y/Y TTM	-2.15%	Profit Margin	9.36%	RSI (14)	34.22	Recom	2.30
Dividend Gr. 3/5Y	- -	Current Ratio	0.98	EPS Q/Q	621.19%	SMA20	-6.89%	Beta	0.64	Target Price	20.07
Payout	150.50%	Debt/Eq	0.81	Sales Q/Q	-4.03%	SMA50	-17.86%	Rel Volume	1.03	Prev Close	15.08
Employees	22000	LT Debt/Eq	0.67	Earnings	Nov 06 BMO	SMA200	-31.40%	Avg Volume	29.42M	Price	14.51
IPO	May 04, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.95% -0.36%	Trades		Volume	29,928,096	Change	-3.78%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	Canaccord Genuity	Buy → Hold	$15
Sep-26-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy	$22
Apr-10-25	Initiated	Redburn Atlantic	Neutral	$23.50
Mar-24-25	Initiated	Evercore ISI	In-line	$25
Jan-06-25	Upgrade	Piper Sandler	Neutral → Overweight	$21 → $26
Dec-12-24	Downgrade	Deutsche Bank	Buy → Hold	$25 → $24
Sep-24-24	Initiated	Jefferies	Buy	$27
Sep-24-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$24
May-28-24	Resumed	Citigroup	Neutral	$21
Apr-11-24	Initiated	Bernstein	Underperform	$18
Apr-03-24	Initiated	William Blair	Mkt Perform
Mar-01-24	Resumed	Goldman	Neutral	$20
Nov-17-23	Initiated	Piper Sandler	Neutral	$20
Sep-11-23	Upgrade	Deutsche Bank	Hold → Buy	$27
Sep-07-23	Initiated	Canaccord Genuity	Buy	$28
Sep-06-23	Initiated	Argus	Hold
Aug-24-23	Upgrade	Goldman	Neutral → Buy	$29
Jul-25-23	Initiated	Edward Jones	Buy
Jun-01-23	Initiated	HSBC Securities	Hold	$27
May-30-23	Initiated	UBS	Neutral	$28

Show Previous Ratings

Today 06:45AM	Kenvue Declares Quarterly Cash Dividend (Business Wire)
Oct-28-25 10:33PM	Beauty product used by millions recalled for possible bacterial danger (TheStreet)
03:23PM	Embattled ?Tylenol Maker Kenvue Hires New Marketing Chief (The Wall Street Journal)
02:44PM	Texas Suit Accuses Tylenol Maker of Hiding a Link to Autism (The Wall Street Journal)
10:51AM	Tylenol Is Tied to Autism, Texas Claims in Suit. Kenvue Stock Shudders. (Barrons.com)
10:42AM	Loading…
10:42AM	Texas sues Kenvue and J&J, Truth Social to offer prediction markets (Yahoo Finance Video)
09:11AM	Texas Sues Kenvue, Alleging Omission of Autism Link From Tylenol Marketing (The Wall Street Journal)
Oct-27-25 01:23PM	High-Quality Stocks Fumbled Without AI. Own Them Anyway. (Barrons.com)
06:45AM	Kenvue to Announce Third Quarter 2025 Results on November 6, 2025 (Business Wire)
04:30AM	3 Healthcare Stocks Paying the Highest Dividends of 2025 (Motley Fool)
Oct-26-25 10:17AM	3 Dividend Stocks With Yields Over 5%. Should You Buy? (24/7 Wall St.)
04:00AM	Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever. (Motley Fool)
Oct-24-25 07:42AM	Canaccord Genuity Reiterates a Buy Rating on Kenvue Inc. (KVUE) (Insider Monkey)
Oct-23-25 03:13AM	Kenvue's Quarterly Earnings Preview: What You Need to Know (Barchart)
Oct-22-25 04:01PM	Tylenol-Maker Kenvues Stock Is Down 30% in 2025. Its Fate May Be in the FDAs Hands. (Barchart)
02:53PM	Loading…
02:53PM	This Billionaire Investor Is Thrilled to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here? (Barchart)
Oct-21-25 10:07PM	Kenvue Inc. (KVUE): A Bull Case Theory (Insider Monkey)
11:18AM	Starboard Value CEO: We're thrilled to own Kenvue at this valuation (CNBC TV)
Oct-20-25 01:23PM	Kenvue Urges FDA to Reject Request for Autism Warning on Tylenol (The Wall Street Journal)
07:24AM	Kenvue at the Cross-Road (GuruFocus.com)
06:39AM	3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October (Motley Fool)
Oct-19-25 01:25PM	Meet the 5%-Yielding Dividend Stock That Could Soar in 2026 (Motley Fool)
Oct-18-25 12:04PM	Johnson & Johnson's M&A Strategy Is the Real Story for Investors (MarketBeat)
Oct-17-25 12:28PM	Top Stock Movers Now: Kenvue, American Express, Truist, Newmont, and More (Investopedia) +8.36%
09:59AM	Is Kenvue (KVUE) One of the Best High Volume Stocks to Buy According to Wall Street Analysts? (Insider Monkey)
Oct-16-25 11:21PM	Analyst Report: Kenvue Inc. (Morningstar Research) -13.22%
06:06PM	Why Kenvue Stock Tumbled by 13% on Thursday (Motley Fool)
04:43PM	Kenvue Stock Falls 13% in Its Worst Day on Record (The Wall Street Journal)
02:39PM	Kenvue Stock Tumbles on a New Challenge. It Isn't Tylenol This Time. (Barrons.com)
01:04PM	Kenvue stock falls as UK talc lawsuits raise liability concerns (Investing.com)
01:02PM	Loading…
01:02PM	J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan (Zacks)
03:20AM	J&Js orthopedics selloff keeps all eyes on a thriving pharma portfolio (Pharma Voice)
01:46AM	J&J faces first UK lawsuits alleging its baby powder caused cancer (Reuters Videos)
Oct-15-25 10:30AM	2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 41% in 12 Months, According to Select Wall Street Analysts (Motley Fool)
02:27AM	Albert Invent Teams Up with Kenvue (KVUE) to Advance Consumer Health Innovation Through AI (Insider Monkey)
Oct-14-25 05:14PM	Analyst Report: Johnson & Johnson (Morningstar Research)
12:00PM	Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI (Business Wire)
09:20AM	J&J lays out plan to splinter orthopedics business into separate company (Associated Press Finance)
08:43AM	Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping. (Barrons.com)
07:44AM	Johnson & Johnson's stock heads for a record after a profit beat and plans for another spinoff (MarketWatch)
06:20AM	Johnson & Johnson Says It Will Spin Off Orthopaedics Business (Barrons.com)
Oct-12-25 08:41AM	Moody's Ratings Downgrades Kenvue Inc. (KVUE) Outlook from "Stable" to "Negative" (Insider Monkey)
Oct-10-25 12:10PM	Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know (Zacks)
04:19AM	Is This Beaten-Down Dividend King a Buy? (Motley Fool)
12:06AM	How Kenvue (KVUE) Earned its Spot Among Today's Most Promising Dividend Stocks (Insider Monkey)
Oct-08-25 09:13AM	These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump (Motley Fool)
Oct-03-25 06:37AM	Barclays Lowers PT on Kenvue (KVUE) to $17 From $20, Keeps an Equal Weight Rating (Insider Monkey)
Oct-01-25 07:38PM	Analyst Report: Johnson & Johnson (Morningstar Research)
11:48AM	This team is guided by science: Kenvue chief hits back at Trump and RFK Jr.s Tylenol autism claims in memo to 20,000 employees (Fortune)
04:44AM	Should You Buy Kenvue Stock After Its 30% Plunge? (Motley Fool)
Sep-29-25 02:47AM	Markets Last Week Roundup: CarMax Woes, Intel Soars, Tylenol Pressure (The Wall Street Journal)
Sep-26-25 09:00PM	Inside the Crisis at Tylenol (The Wall Street Journal)
07:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:19PM	Trump reaffirms Tylenol claims, AppLovin gets price target lifts (Yahoo Finance Video)
09:46AM	CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls (The Fly)
09:06AM	Rothschild upgrades Kenvue after Tylenol scare wipes $10 billion in market value (Investing.com)
08:55AM	Jim Cramer Discusses Kenvue Inc. (KVUE) & Legal Issues (Insider Monkey)
Sep-24-25 09:00PM	RFK Jr.s Team Wanted to Tout an Autism Therapy. He Went After Tylenol Instead. (The Wall Street Journal)
01:12PM	As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stocks Here? (Barchart)
09:47AM	Stocks to Watch Wednesday: Alibaba, Lithium Americas, GM (The Wall Street Journal)
09:38AM	Trump links autism to Tylenol ingredient use during pregnancy here's what to know (CNBC TV)
09:37AM	Tylenol Maker Kenvue Faces Mounting Crisis After Trump Blast (Bloomberg)
07:13AM	These Stocks Are Moving the Most Today: Alibaba, Micron, Lithium Americas, Albemarle, GM, Thor Industries, and More (Barrons.com)
05:44AM	These Stocks Are Moving the Most Today: Alibaba, Micron, Lithium Americas, Albemarle, GM, Kenvue, and More (Barrons.com)
05:25AM	Analyst Report: Johnson & Johnson (Morningstar Research)
Sep-23-25 06:02PM	Podcast: Tech Sector Leads U.S. Stocks Lower (The Wall Street Journal)
05:11PM	Analyst Report: Kenvue Inc. (Morningstar Research)
05:00PM	Stocks to Watch Recap: TSMC, Boeing, Kenvue, AutoZone (The Wall Street Journal)
04:35PM	Kenvue Stock Rebounds After Trump Links Tylenol to Autism. Heres Why. (Barrons.com)
04:18PM	These Stocks Moved the Most Today: Kenvue, Nvidia, Firefly Aerospace, Boeing, Halliburton, Micron, Vistra, and More (Barrons.com)
02:53PM	Kenvue (KVUE) Falls to New All-Time Low as Trump Hits Tylenol (Insider Monkey)
02:46PM	Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism (Investopedia)
01:59PM	Kenvue stock rebounds as Trump's Tylenol claims face pushback (Reuters Videos)
12:56PM	These Stocks Are Moving the Most Today: Kenvue, Nvidia, Firefly Aerospace, Boeing, Halliburton, Micron, Vistra, and More (Barrons.com)
11:55AM	Stocks to Watch Tuesday: TSMC, Boeing, Kenvue, AutoZone (The Wall Street Journal)
11:08AM	Trumps paracetamol claims wipe billions off UK drugmakers (The Telegraph)
10:54AM	Pharmaceutical Stock Bounces Off Record Lows (Schaeffer's Research)
10:35AM	Trump admin draws unproven link between autism and Tylenol ingredient use during pregnancy (CNBC TV)
10:35AM	Shares of Kenvue rebound today after Trump admin ties use of acetaminophen to autism (CNBC TV)
10:24AM	Kenvue rebounds as doctors deny Trump's Tylenol, autism claim (Yahoo Finance Video)
10:11AM	Kenvue Braces for Wave of New Lawsuits Over Tylenols Potential Link to Autism (The Wall Street Journal)
09:34AM	Trump Warns Against Tylenol in Pregnancy Over Unproven Autism Fears (Bloomberg)
09:29AM	Kenvue, AutoZone earnings, Orsted wind farm: Trending Tickers (Yahoo Finance Video)
09:23AM	Podcast: Kenvue Braces for Lawsuits Over Tylenol's Alleged Autism Link (The Wall Street Journal)
08:00AM	Tylenol maker Kenvue stock rebounds after Trump's baseless autism claim (Quartz)
08:00AM	Boeing, Orsted, Kenvue, Google: Trending Stocks (Yahoo Finance Video)
07:51AM	Kenvue Stock Bounces Back After Trump Links Tylenol to Autism. Here's Why. (Barrons.com)
07:49AM	Tylenol maker rebounds a day after Trump's unfounded claims about its safety (Associated Press Finance)
06:47AM	Nvidia Exposes a Stock Market Problem. How the Fed Can Solve It. (Barrons.com)
06:38AM	Morning Bid: Pain thresholds (Reuters)
06:28AM	Kenvue shares bounce off record low, and other early market movers (MarketWatch)
05:51AM	These Stocks Are Moving the Most Today: Kenvue, Nvidia, Firefly Aerospace, Apple, Plug Power, and More (Barrons.com)
05:40AM	Kenvue shares rise despite Trump linking painkiller to autism risk (Investing.com)
05:27AM	Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link (MarketWatch)
04:00AM	Tylenol-maker Kenvue shares bounce, Trump claims face pushback (Reuters)
02:41AM	Heard on the Street Tuesday Recap: Even Tylenol Cant Cool This AI Fever (The Wall Street Journal)
Sep-22-25 11:49PM	Global shares mostly rise, cheered by US stocks setting more records (Associated Press Finance) -7.47%
09:41PM	Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles (TheStreet)
07:49PM	Trump Warns Pregnant Women to Avoid Tylenol (The Wall Street Journal)
07:10PM	Trump Links Autism to Use of Tylenol During Pregnancy. Kenvue Stock Hits Record Low. (Barrons.com)

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Howlett Heather	VP & Chief Accounting Officer	Oct 03 '25	Option Exercise	0.00	27,181	0	30,901	Oct 07 04:32 PM
Dyer Russell	Chief Corp. Affairs Officer	Jun 03 '25	Option Exercise	0.00	2,669	0	2,669	Jun 05 04:27 PM
Ruh Paul	Former Officer	May 16 '25	Proposed Sale	24.03	100,531	2,415,700		May 16 02:23 PM
Ruh Paul	Former Officer	May 12 '25	Proposed Sale	24.26	50,000	1,213,000		May 12 10:42 AM
Lawson Carlton	Group President EMEA & LA	Mar 13 '25	Sale	23.03	17,100	393,813	56,316	Mar 14 04:23 PM
Lawson Carlton	Officer	Mar 13 '25	Proposed Sale	23.03	17,100	393,871		Mar 13 02:12 PM
Lawson Carlton	Group President EMEA & LA	Mar 05 '25	Option Exercise	0.00	7,422	0	73,416	Mar 07 05:03 PM
Meurer Jan	Group President, North America	Mar 05 '25	Option Exercise	0.00	6,913	0	35,677	Mar 07 05:03 PM
Tillett Caroline	Chief Scientific Officer	Mar 05 '25	Option Exercise	0.00	4,268	0	45,658	Mar 07 05:03 PM
Howlett Heather	VP & Chief Accounting Officer	Mar 05 '25	Option Exercise	0.00	2,613	0	4,582	Mar 07 05:03 PM
Ruh Paul	Chief Financial Officer	Mar 05 '25	Option Exercise	0.00	7,422	0	59,996	Mar 07 05:02 PM
Tavares Bernardo	Chief Tech & Data Officer	Mar 05 '25	Option Exercise	0.00	1,503	0	14,582	Mar 07 05:02 PM
Alvarado Luani	Chief People Officer	Mar 05 '25	Option Exercise	0.00	4,107	0	32,688	Mar 07 05:02 PM
Xie Bing	Group President APAC	Mar 05 '25	Option Exercise	0.00	6,169	0	50,688	Mar 07 05:02 PM
England Charmaine	Chief Growth Officer	Mar 05 '25	Option Exercise	0.00	2,911	0	30,407	Mar 07 05:02 PM
Orlando Matthew	General Counsel	Mar 05 '25	Option Exercise	0.00	6,169	0	28,439	Mar 07 05:01 PM
Stevens Meredith	Chief Operations Officer	Mar 05 '25	Option Exercise	0.00	5,971	0	66,865	Mar 07 05:01 PM
Mongon Thibaut	Chief Executive Officer	Mar 05 '25	Option Exercise	0.00	32,969	0	233,333	Mar 07 05:01 PM
Ruh Paul	Chief Financial Officer	Feb 14 '25	Option Exercise	0.00	31,863	0	59,790	Feb 18 06:30 PM
Ruh Paul	Chief Financial Officer	Feb 13 '25	Option Exercise	0.00	2,600	0	31,596	Feb 18 06:30 PM
Howlett Heather	VP & Chief Accounting Officer	Feb 13 '25	Option Exercise	0.00	1,556	0	2,544	Feb 18 06:30 PM
Stevens Meredith	Chief Operations Officer	Feb 14 '25	Option Exercise	0.00	34,278	0	67,771	Feb 18 06:30 PM
Stevens Meredith	Chief Operations Officer	Feb 13 '25	Option Exercise	0.00	3,215	0	37,070	Feb 18 06:30 PM
Lawson Carlton	Group President EMEA & LA	Feb 14 '25	Option Exercise	0.00	41,464	0	65,994	Feb 18 06:30 PM
Lawson Carlton	Group President EMEA & LA	Feb 13 '25	Option Exercise	0.00	4,519	0	24,530	Feb 18 06:30 PM
Xie Bing	Group President APAC	Feb 14 '25	Option Exercise	0.00	40,323	0	58,737	Feb 18 06:29 PM
Xie Bing	Group President APAC	Feb 13 '25	Option Exercise	0.00	4,126	0	26,351	Feb 18 06:29 PM
Mongon Thibaut	Chief Executive Officer	Feb 14 '25	Option Exercise	0.00	162,365	0	270,403	Feb 18 06:29 PM
Mongon Thibaut	Chief Executive Officer	Feb 13 '25	Option Exercise	0.00	8,438	0	124,220	Feb 18 06:29 PM
Orlando Matthew	General Counsel	Feb 14 '25	Option Exercise	0.00	11,490	0	25,763	Feb 18 06:29 PM
Orlando Matthew	General Counsel	Feb 13 '25	Option Exercise	0.00	1,371	0	16,209	Feb 18 06:29 PM
Tavares Bernardo	Chief Tech & Data Officer	Feb 14 '25	Option Exercise	0.00	9,416	0	15,980	Feb 18 06:29 PM
Tavares Bernardo	Chief Tech & Data Officer	Feb 13 '25	Option Exercise	0.00	1,333	0	8,261	Feb 18 06:29 PM
Tillett Caroline	Chief Scientific Officer	Feb 14 '25	Option Exercise	0.00	26,766	0	47,625	Feb 18 06:29 PM
Tillett Caroline	Chief Scientific Officer	Feb 13 '25	Option Exercise	0.00	3,000	0	24,490	Feb 18 06:29 PM
Meurer Jan	Group President, North America	Feb 14 '25	Option Exercise	0.00	16,202	0	32,933	Feb 18 06:29 PM
Meurer Jan	Group President, North America	Feb 13 '25	Option Exercise	0.00	2,119	0	19,271	Feb 18 06:29 PM
England Charmaine	Chief Growth Officer	Feb 14 '25	Option Exercise	0.00	13,038	0	31,796	Feb 18 06:29 PM
England Charmaine	Chief Growth Officer	Feb 13 '25	Option Exercise	0.00	1,289	0	21,075	Feb 18 06:29 PM
Alvarado Luani	Chief People Officer	Feb 14 '25	Option Exercise	0.00	17,009	0	32,586	Feb 18 06:28 PM
Alvarado Luani	Chief People Officer	Feb 13 '25	Option Exercise	0.00	1,830	0	17,675	Feb 18 06:28 PM
Meurer Jan	Group President, North America	Dec 01 '24	Option Exercise	0.00	2,330	0	18,345	Dec 03 06:38 PM
Tillett Caroline	Chief Scientific Officer	Dec 01 '24	Option Exercise	0.00	1,498	0	22,257	Dec 03 06:38 PM
Stevens Meredith	Chief Operations Officer	Dec 01 '24	Option Exercise	0.00	2,930	0	35,008	Dec 03 06:38 PM
Ruh Paul	Chief Financial Officer	Dec 01 '24	Option Exercise	0.00	4,095	0	30,894	Dec 03 06:38 PM
Xie Bing	Group President APAC	Dec 01 '24	Option Exercise	0.00	1,531	0	22,811	Dec 03 06:38 PM
Mongon Thibaut	Chief Executive Officer	Dec 01 '24	Option Exercise	0.00	7,323	0	119,528	Dec 03 06:37 PM
Alvarado Luani	Chief People Officer	Dec 01 '24	Option Exercise	0.00	2,164	0	16,948	Dec 03 06:37 PM
Orlando Matthew	General Counsel	Dec 01 '24	Option Exercise	0.00	4,261	0	15,778	Dec 03 06:37 PM
Lawson Carlton	Group President EMEA & LA	Dec 01 '24	Option Exercise	0.00	1,731	0	20,011	Dec 03 06:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KVUE

Kenvue Inc

Upgrade your FINVIZ experience